Kythera's chin fat drug OK'd in US

There may soon be fewer double chins in the US, now that the FDA has given the go-ahead to Kythera Biopharmaceuticals to market Kybella (deoxycholic acid), previously known as ATX-101, as a treatment for adults to improve the appearance of moderate-to-severe convexity or fullness associated with submental fat.